StockIQ.techElevance Health Inc. (ELV) Stock Analysis
Free AI-powered analysis and research for Elevance Health Inc. stock
Sector: Healthcare
ELV snapshot
Data as of 12 Oct 2026 close. Updated daily.
Elevance Health Inc. scores 72/100 on StockIQ's model, which reads as positive signals overall. The price is above its 200-day average and at 91% of its 52-week range, up 20.1% over the past year. Latest reported figures show a profit margin of 2.5%, return on equity of 11.1% and revenue growth of +1.4%.
What is driving the score
- Uptrend: +7
- MACD Bullish: +8
- Weak Profit Margin (2.5%): -8
- Strong Long-term Uptrend: +8
- Healthy Momentum (+20.1% over 1 year): +7
Automated, general information only – not financial advice. Scores can be wrong. How the score works
Full ELV report
Elevance Health Inc. (ELV) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze ELV Now →📰 Latest Update
Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key Metrics
Fri, October 16, 2026 at 12:15 PM UTC 2 min read
Elevance Health (ELV) has released its Q3 outlook, with Wall Street estimating key metrics that reflect the company's performance amid a challenging healthcare landscape. Investors should pay attention to these projections, as they could influence stock valuation and market sentiment. The outlook may provide insights into Elevance's ability to navigate regulatory changes and competitive pressures, which are critical for long-term growth and profitability.